Metabolic
Credibility 80
GLP-1 receptor agonist medications for weight loss: Sociodemographic patterns of awareness, use, and access in a U.S. national cohort.
October 25, 2026 · Annals of epidemiology
Key takeaway
This study found that more Black adults are using new weight loss medications compared to other groups. However, many still face challenges getting these medicines, especially if they have trouble with healthcare access or lower incomes. This matters because it highlights that while we're showing interest, barriers might keep us from getting the care we need.
Why this matters for our communities
Research in metabolic helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Metabolic
December 31, 2026"Sometimes it's the bullying": an exploratory qualitative study of church leaders' perceptions of dietary health of black American children and youth.Read December 31, 2026What unhealthy food and beverage advertisements appeal to- and promote obesity amongst- adolescent children in urban South Africa?Read December 6, 2026Program and Family Predictors of Retention and Weight Loss Among Black Youth in a Pediatric Weight Management Program.Read